LIFE ATTENUATED VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Life Attenuated Vaccines Market, By Product Type (Bacterial and Viral), By Technology (Classical Techniques, Live Attenuation, Inactivated/Killed, Advanced Techniques, Recombinant DNA Technology, and Viral Vector Technology), By Indication (Tuberculosis, Measles, Rotavirus, Yellow Fever, Oral Polio, and Others), By Mode of Administration (Injectable, Intranasal, Oral, and Others), By Age Group (Pediatric Vaccines, Adult Vaccines, and Geriatric Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 04 Mar, 2025
Code: CMI7758
Pages: 160
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

The global life attenuated vaccines market size is estimated to be valued at USD 29.50 Bn in 2025 and is expected to expand at a CAGR of 11.50% from 2025 to 2032. Life attenuated vaccines use weakened or attenuated live microorganisms or pathogens to trigger immunity. When administered to a patient, these vaccines mimic a natural infection but do not cause the disease. Common life attenuated vaccines include measles, mumps, rubella (MMR), varicella, rotavirus, and yellow fever vaccines. Growing awareness regarding preventive healthcare and rising immunization programs worldwide are expected to support the growth of this market over the forecast period.

Market Dynamics:

Increasing investments by government bodies in immunization programs across developing nations are expected to drive the market growth during the forecast period. Moreover, rising incidence of various diseases, such as measles, mumps, and rubella, is further propelling the demand for life attenuated vaccines. However, high costs associated with vaccine development and stringent regulations for approval are the major factors anticipated to restrain the market growth. On the flip side, ongoing research & development activities to develop vaccines for new diseases and approval of newer attenuated vaccines are likely to present attractive growth opportunities for the players in the market.

Key Features of the Study:

- This report provides in-depth analysis of the global life attenuated vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global life attenuated vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Pfizer, Inc., Astellas Pharma Inc., Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute of India Pvt. Ltd., Bharat Biotech, Takeda Pharmaceutical Company, Novartis AG, BioNTech SE, and Sinovac Biotech Ltd.

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- The global life attenuated vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life attenuated vaccines market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Bacterial
- Viral
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Classical Techniques
- Live Attenuation
- Inactivated/Killed
- Advanced Techniques
- Recombinant DNA Technology
- Viral Vector Technology
Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Tuberculosis
- Measles
- Rotavirus
- Yellow Fever
- Oral Polio
- Others
Mode of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable
- Intranasal
- Oral
- Others
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Vaccines
- Adult Vaccines
- Geriatric Vaccines
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Merck & Co.
- Pfizer, Inc.
- Astellas Pharma Inc.
- Johnson & Johnson
- CSL Limited
- Emergent BioSolutions, Inc.
- MedImmune, LLC
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Takeda Pharmaceutical Company
- Novartis AG
- BioNTech SE
- Sinovac Biotech Ltd.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Life Attenuated Vaccines Market, By Product Type
  - Global Life Attenuated Vaccines Market, By Technology
  - Global Life Attenuated Vaccines Market, By Indication
  - Global Life Attenuated Vaccines Market, By Mode of Administration
  - Global Life Attenuated Vaccines Market, By Age Group
  - Global Life Attenuated Vaccines Market, By Distribution Channel
  - Global Life Attenuated Vaccines Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Life Attenuated Vaccines Market, By Product Type, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Bacterial
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Technology, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Classical Techniques
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Live Attenuation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inactivated/Killed
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Advanced Techniques
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant DNA Technology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral Vector Technology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Indication, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Tuberculosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Measles
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rotavirus
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Yellow Fever
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral Polio
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Mode of Administration, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intranasal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Age Group, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Pediatric Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Distribution Channel, 2025-2032, (USD Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Global Life Attenuated Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Astellas Pharma Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CSL Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Emergent BioSolutions, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- MedImmune, LLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bharat Biotech
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioNTech SE
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sinovac Biotech Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Life Attenuated Vaccines Market' - Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now